Skip to content

Clinical study on the effect of moxibustion smoke concentrations for pain and motor dysfunction in patients on stage I of shoulder hand syndrome (SHS) after cerebral stroke

Clinical study on the effect of moxibustion smoke concentrations for pain and motor dysfunction in patients on stage I of shoulder hand syndrome (SHS) after cerebral stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004383
Enrollment
Unknown
Registered
2021-02-04
Start date
2021-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder hand syndrome (SHS) after stroke

Interventions

Sponsors

Huguosi TCM Hospital, Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Conformed by the diagnostic standards of Western medicine for cerebral stroke; 2. conformed by the diagnostic standards of SHS stage I; 3. cerebrovascular diseases confirmed by imaging (including but not limited to head CT or MRI); ischemic stroke within two times, and the treatment time after the onset is between two weeks and three months; 4. the gender unlimited; 5. the age between 50-76 years old; 6. the patient's vital signs are stable, and they volunteer to participate in and actively cooperate to complete the project; 7. they are full awareness of study and sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Cerebrovascular diseases other than stroke; 2. patients with abnormal pain threshold caused by lesions in thalamus; 3. patients with other serious internal diseases; 4. patients with serious emotional disorders after stroke; 5. patients with dislocation and subluxation of shoulder joint; 6. patients with peri-arthritis of shoulder and local soft tissue injury with serious activities have been diagnosed before stroke; 7. intolerant of treatment.

Design outcomes

Primary

MeasureTime frame
visual analogue scale, VAS;

Secondary

MeasureTime frame
somatosensory evoked potential;Muscle rapid measurement;motor evoked potential (MEP);Upper limbs Fugl-Meyer Assessment (FMA);Modified Brathel Index;

Countries

China

Contacts

Public ContactMeng Xiaonan

Huguosi TCM Hospital, Affiliated to Beijing University of Chinese Medicine

mengxiaonan.cn@gmail.com+86 13810988685

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026